What contract did Pro Medicus (ASX:PME) just secure?

Pro Medicus has signed a major seven-year, $90 million deal with Beth Israel Lahey Health, a large integrated US healthcare system. The agreement will see the company deploy its flagship cloud-based Visage 7 Enterprise Imaging Platform across the provider's network of 14 hospitals.

Why is this $90 million US deal significant for Pro Medicus (ASX:PME)?

This transaction-based contract reinforces accelerating market momentum for Pro Medicus’ cloud-native diagnostic imaging strategy in North America. Winning a major tier-one hospital network confirms that large-scale healthcare operators are increasingly phasing out legacy on-premise systems in favour of modern CloudPACS infrastructure.

What is the operational timeline for the Visage 7 implementation?

Implementation planning between Pro Medicus and Beth Israel Lahey Health is scheduled to begin immediately. The operational target for the platform to officially go live across the hospital network is set for the first quarter of the 2027 calendar year.

Which geographical markets will this contract cover?

The contract directly expands Pro Medicus’ footprint in the northeastern United States healthcare sector. The rollout will support regional clinical operations and patient bases distributed throughout eastern Massachusetts and southern New Hampshire.

What executive leadership change did Pro Medicus (ASX:PME) announce alongside the deal?

Pro Medicus announced that Clayton Hatch, the company's long-serving Head of Business Operations and Investor Relations, has resigned effective 14 August. Hatch is a corporate veteran who spent 18 years at the company, including a crucial stint as Chief Financial Officer during its primary global expansion phase.

Does the executive resignation change the medium-term investment thesis for Pro Medicus (ASX:PME)?

While losing an 18-year veteran introduces transitional friction, the core investment thesis remains intact because commercial execution continues to deliver. Securing a $90 million enterprise contract simultaneously demonstrates that day-to-day business momentum and enterprise sales cycles are decoupled from individual executive departures.

Image for illustrative purposes only. Not a real photo.

Pro Medicus secures $90M US hospital contract

Written by Brie CarterPublished May. 18 2026Last Updated May. 18 2026

Medical imaging IT provider Pro Medicus (ASX:PME) has secured a major seven-year, $90 million contract with US healthcare system Beth Israel Lahey Health.

Under the agreement, the ASX-listed company will implement its flagship cloud-based Visage 7 Enterprise Imaging Platform across the Boston-based network's 14 hospitals.

The rollout will serve regional patient bases throughout eastern Massachusetts and southern New Hampshire, with immediate implementation planning aimed at a targeted first-quarter go-live in the 2027 calendar year.

In a simultaneous corporate update, Pro Medicus announced that Clayton Hatch, its long-serving head of business operations and investor relations, has resigned effective Aug. 14.

Hatch departs after an 18-year tenure, having previously navigated the company’s pivotal global expansion as CFO.

Despite executive transition, the North American transaction-based contract underlines accelerating momentum for the company's CloudPACS strategy as major tier-one hospital networks increasingly phase out legacy diagnostic systems.

At the time of reporting, Pro Medicus’ share price was $129.74.